Privia Health (PRVA) Receivables (2020 - 2026)

Privia Health's Receivables history runs 7 years deep, the most recent figure standing at $513.7 million for Q1 2026.

• On a quarterly basis, Receivables rose 32.14% year-over-year to $513.7 million in Q1 2026; TTM through Mar 2026 was $513.7 million, a 32.14% increase from a year earlier, with the FY2025 full-year figure at $400.9 million, up 26.8% from the prior year.
• Receivables grew to $513.7 million in Q1 2026 per PRVA's latest filing, from $400.9 million in the prior quarter.
• Across five years, Receivables topped out at $513.7 million in Q1 2026 and bottomed at $166.2 million in Q1 2022.
• The 5-year median for Receivables is $346.1 million (2024), against an average of $336.8 million.
• Across the five-year window, Receivables surged 150.39% in 2022 and climbed 8.74% in 2024, its largest moves.
• Year by year, Receivables stood at $189.6 million in 2022, then surged by 53.36% to $290.8 million in 2023, then grew by 8.74% to $316.2 million in 2024, then increased by 26.8% to $400.9 million in 2025, then increased by 28.13% to $513.7 million in 2026.
• Per Business Quant, the three latest PRVA Receivables figures stand at $513.7 million (Q1 2026), $400.9 million (Q4 2025), and $499.0 million (Q3 2025).